Zydus Lifesciences Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Dec '24
Sep '24
Jun '24
Mar '24
Dec '23
Total Qtr Revenue cr
5,326.60
5,305.20
6,270.70
5,690.20
4,542.90
Other Income Qtr Cr57.5068.2063.20156.4037.70
Operating Revenues Qtr5,269.105,237.006,207.505,533.804,505.20

*All values are in Cr.

Operating Expenses Qtr
3,881.50
3,775.60
4,123.50
3,903.30
3,402.80
Operating Profit Qtr
1,387.60
1,461.40
2,084.00
1,630.50
1,102.40
EBIDT Qtr Cr
1,444.80
1,529.90
2,147.20
1,790.10
1,161.90
Depreciation Qtr
229.00
233.60
215.30
205.30
194.80
Net Profit Qtr
1,026.20
920.20
1,482.50
1,246.10
789.60
Basic EPS Qtr
10.17
9.06
14.11
11.69
7.80
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -